Internal Medicine, Rheumatology · Spring Lake, NJ
NPI
1699752634
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
0
Medicare group memberships
Hospitals
3
Hospital affiliations
207 Route 71
Spring Lake, NJ, 07762
Phone (732) 359-7232
Medicare paid, 2024
$972K
132,667 services
Medicare patients, 2024
442
Average age 78
Drug cost, 2024
$925K
2,757 prescriptions
Company payments, 2025
$2,084
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ileana Antoniadis was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 69,260 times for 19 patients. In total Ileana Antoniadis billed 132,667 services in 33 codes, and Medicare paid $972K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-03-25.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 69,260 | 19 | $3.63 | $252K |
| J0897 Injection, denosumab, 1 mg | Office | 12,960 | 127 | $20.65 | $268K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 6,170 | 36 | $0.10 | $633 |
| 99214 Office E&M - Established | Office | 1,194 | 398 | $89.33 | $107K |
| J3304 Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 1,024 | 12 | $13.75 | $14K |
| 85651 Clinical Chemistry | Office | 630 | 325 | $4.18 | $2,633 |
| 96401 Chemotherapy Administration | Office | 458 | 20 | $53.08 | $24K |
| 96372 Injection Administration | Office | 297 | 130 | $10.60 | $3,148 |
| 99213 Office E&M - Established | Office | 245 | 150 | $64.20 | $16K |
| 99212 Office E&M - Established | Office | 143 | 79 | $40.25 | $5,756 |
| 20610 Joint Injection | Office | 93 | 49 | $48.47 | $4,508 |
| 99204 Office E&M - New | Office | 68 | 68 | $119.91 | $8,154 |
| 36415 Venipuncture Blood Collection | Office | 37 | 34 | $8.65 | $320 |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 18 | 11 | $4.06 | $72.99 |
By year: 2022 $995K for 117,074 services; 2023 $975K for 118,407 services; 2024 $972K for 132,667 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85651 Clinical Chemistry | 630 | 325 | $4.18 | $2,633 |
| 36415 Venipuncture Blood Collection | 37 | 34 | $8.65 | $320 |
Medicare prescription drug claims, 2024
In 2024, the drug Ileana Antoniadis prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 253 prescriptions and refills. In total Ileana Antoniadis wrote 2,757 Medicare prescriptions that cost $925K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 253 | 555 | 62 | $10K |
| Meloxicam Generic | 165 | 316 | 62 | $926 |
| Methotrexate Methotrexate Sodium | 149 | 314 | 36 | $3,570 |
| Prednisone Generic | 142 | 200 | 39 | $1,154 |
| Duloxetine Hcl Generic | 131 | 222 | 25 | $2,173 |
| Celecoxib Generic | 127 | 181 | 37 | $1,690 |
| Alendronate Sodium Generic | 127 | 288 | 34 | $1,547 |
| Tramadol Hcl-Acetaminophen Tramadol Hcl/Acetaminophen | 117 | 117 | 27 | $2,206 |
| Tramadol Hcl Generic | 109 | 109 | 31 | $1,186 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 102 | 102 | 28 | $1,705 |
| Gabapentin Generic | 97 | 141 | 27 | $1,166 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 93 | 93 | 19 | $2,125 |
| Ibandronate Sodium Generic | 78 | 218 | 26 | $3,547 |
| Allopurinol Generic | 69 | 165 | 18 | $976 |
| Diclofenac Sodium Generic | 63 | 84 | 18 | $1,072 |
Brand drugs: - claims; generic drugs: 2,489 claims; opioid claims: 604.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ileana Antoniadis $2,084 ($2,084 in general payments such as food, travel and fees) from 21 companies. The largest payer was Abbvie Inc. with $529.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 21 | $529 |
| Janssen Biotech, Inc. JNJ | 14 | $351 |
| Mallinckrodt Hospital Products Inc. | 10 | $188 |
| UCB, Inc. UCB.BR | 11 | $165 |
| United Therapeutics Corporation UTHR | 2 | $125 |
| Pfizer Inc. PFE | 7 | $116 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $103 |
| Sandoz Inc. SDZ.SW | 4 | $82.49 |
| ANI Pharmaceuticals, Inc. ANIP | 4 | $71.78 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $69.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.